Trulicity is a brand-name, injectable dulaglutide medication approved by the U.S. Food and Drug Administration (FDA) to treat ...
New indication reflects distinct patient population in the REWIND study, including primarily people with multiple cardiovascular risk factors but without established cardiovascular disease ...
@2024 - All Right Reserved.
AWARD-11 showed 3.0 mg and 4.5 mg doses led to additional blood sugar control; as a secondary endpoint, both doses also led to weight loss INDIANAPOLIS, Sept. 3, 2020 /PRNewswire/ -- The U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results